Linked Life Data

20855664

Source:http://linkedlifedata.com/resource/pubmed/id/20855664

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2010-10-5
pubmed:abstractText
Growth-differentiation factor-15 (GDF-15) is emerging as a prognostic biomarker in patients with coronary artery disease. Little is known about GDF-15 as a biomarker in patients with heart failure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
122
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1387-95
pubmed:meshHeading
pubmed-meshheading:20855664-Aged, pubmed-meshheading:20855664-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:20855664-Atrial Fibrillation, pubmed-meshheading:20855664-Biological Markers, pubmed-meshheading:20855664-Diabetic Angiopathies, pubmed-meshheading:20855664-Female, pubmed-meshheading:20855664-Growth Differentiation Factor 15, pubmed-meshheading:20855664-Heart Failure, pubmed-meshheading:20855664-Humans, pubmed-meshheading:20855664-Hypertension, pubmed-meshheading:20855664-Male, pubmed-meshheading:20855664-Middle Aged, pubmed-meshheading:20855664-Placebos, pubmed-meshheading:20855664-Prognosis, pubmed-meshheading:20855664-Regression Analysis, pubmed-meshheading:20855664-Risk Assessment, pubmed-meshheading:20855664-Risk Factors, pubmed-meshheading:20855664-Severity of Illness Index, pubmed-meshheading:20855664-Tetrazoles, pubmed-meshheading:20855664-Valine
pubmed:year
2010
pubmed:articleTitle
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
pubmed:affiliation
Cardiology 111-C, VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA. anand001@umn.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study